» Articles » PMID: 29927449

Real-time Observation of Leukocyte-endothelium Interactions in Tissue-engineered Blood Vessel

Overview
Journal Lab Chip
Specialties Biotechnology
Chemistry
Date 2018 Jun 22
PMID 29927449
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Human cell-based 3D tissue constructs play an increasing role in disease modeling and drug screening. Inflammation, atherosclerosis, and many autoimmune disorders involve the interactions between immune cells and blood vessels. However, it has been difficult to image and model these interactions under realistic conditions. In this study, we fabricated a perfusion and imaging chamber to allow the real-time visualization of leukocyte perfusion, adhesion, and migration inside a tissue-engineered blood vessel (TEBV). We monitored the elevated monocyte adhesion to the TEBV wall and transendothelial migration (TEM) as the TEBV endothelium was activated by the inflammatory cytokine TNF-α. We demonstrated that treatment with anti-TNF-α or an NF-kB signaling pathway inhibitor would attenuate the endothelium activation and reduce the number of leukocyte adhesion (>74%) and TEM events (>87%) close to the control. As the first demonstration of real-time imaging of dynamic cellular events within a TEBV, this work paves the way for drug screening and disease modeling in TEBV-associated microphysiological systems.

Citing Articles

Innovative Atherosclerosis Models: Advancing Pathophysiology and Translational Research.

Jiang H, Liao Y, Zhu M, Jiramonai L, Wu H, Zhong Y Research (Wash D C). 2025; 8:0617.

PMID: 40046514 PMC: 11881979. DOI: 10.34133/research.0617.


Tiny Organs, Big Impact: How Microfluidic Organ-on-Chip Technology Is Revolutionizing Mucosal Tissues and Vasculature.

Dasgupta I, Rangineni D, Abdelsaid H, Ma Y, Bhushan A Bioengineering (Basel). 2024; 11(5).

PMID: 38790343 PMC: 11117503. DOI: 10.3390/bioengineering11050476.


Integrating Computational and Biological Hemodynamic Approaches to Improve Modeling of Atherosclerotic Arteries.

Vuong T, Bartolf-Kopp M, Andelovic K, Jungst T, Farbehi N, Wise S Adv Sci (Weinh). 2024; 11(26):e2307627.

PMID: 38704690 PMC: 11234431. DOI: 10.1002/advs.202307627.


Atherosclerotic three-layer nanomatrix vascular sheets for high-throughput therapeutic evaluation.

Chen J, Zhang X, Cross Jr R, Ahn Y, Huskin G, Evans W Biomaterials. 2024; 305():122450.

PMID: 38169190 PMC: 10843643. DOI: 10.1016/j.biomaterials.2023.122450.


Cardiovascular Tissue Engineering Models for Atherosclerosis Treatment Development.

Tscheuschner L, Tzafriri A Bioengineering (Basel). 2023; 10(12).

PMID: 38135964 PMC: 10740643. DOI: 10.3390/bioengineering10121373.


References
1.
Fernandez C, Achneck H, Reichert W, Truskey G . Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs). Curr Opin Chem Eng. 2014; 3:83-90. PMC: 3915872. DOI: 10.1016/j.coche.2013.12.001. View

2.
Seifu D, Purnama A, Mequanint K, Mantovani D . Small-diameter vascular tissue engineering. Nat Rev Cardiol. 2013; 10(7):410-21. DOI: 10.1038/nrcardio.2013.77. View

3.
Cedervall J, Dimberg A, Olsson A . Tumor-Induced Local and Systemic Impact on Blood Vessel Function. Mediators Inflamm. 2016; 2015:418290. PMC: 4685129. DOI: 10.1155/2015/418290. View

4.
Mestas J, Ley K . Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2009; 18(6):228-32. PMC: 2650852. DOI: 10.1016/j.tcm.2008.11.004. View

5.
Stucht D, Danishad K, Schulze P, Godenschweger F, Zaitsev M, Speck O . Highest Resolution In Vivo Human Brain MRI Using Prospective Motion Correction. PLoS One. 2015; 10(7):e0133921. PMC: 4520483. DOI: 10.1371/journal.pone.0133921. View